The American Kidney Fund (AKF) was joined by a multidisciplinary panel of experts to delve into the utility of the cystatin C test in diagnosing kidney disease. The webinar is generously sponsored by Gentian Diagnostics.

Measurement of serum cystatin C is gaining a greater role in the estimation of kidney function, particularly as the kidney community considers moving away from the current race-based eGFR equation which depends on creatinine measurement.

Topics include:
-Epidemiological argument for measuring cystatin C
-Benefits of cystatin C related to diagnosis, risk classification, and racial bias
-Practical barriers to ordering the cystatin C test

Participants of this webinar include:
Moderator:
Silas Norman, MD, MPH
University of Michigan

Panelists:
Josef Coresh, MD, PhD
Johns Hopkins University
Michelle Estrella, MD, MHS
University of California - San Francisco
Amy Karger, MD, PhD
University of Minnesota
Michael Shlipak, MD, MPH
University of California - San Francisco

свернуть